XML 25 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTANGIBLE ASSETS (Details) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 9,625,938 $ 9,625,938
Less: accumulated amortization (5,955,101) (5,479,953)
Intangible assets, net 3,670,837 4,145,985
Amortization expense 475,148 476,450
Future aggregate amortization expense for intangible assets [Abstract]    
2014 475,148  
2015 475,148  
2016 476,450  
2017 475,148  
2018 475,148  
2019 & Beyond 1,293,795  
Total 3,670,837  
Patents [Member] | Amlexanox (Aphthasol) [Member]
   
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross 2,090,000 2,090,000
Patents [Member] | Amlexanox (OraDiscA) [Member]
   
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross 6,873,080 6,873,080
Patents [Member] | OraDisc [Member]
   
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross 73,000 73,000
Patents [Member] | Hydrogel Nanoparticle Aggregate [Member]
   
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 589,858 $ 589,858